Clinical experiences of patients with catecholaminergic polymorphic ventricular tachycardia

Cardiology in the Young

Volumn 19, Issue 1, 2009, Pages 45-52

  Çeliker, Alpay ^a   Erdoǧan, Ilkay ^a   Karagöz, Tevfik ^a   Özer, Sema ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Childhood; Implantable cardioverter defibrillators; Syncope

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOPRENALINE; METOPROLOL; NADOLOL; PROPRANOLOL; VERAPAMIL;

ADOLESCENT; ARTICLE; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DEFIBRILLATOR; DIAGNOSTIC PROCEDURE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; GENETIC ANALYSIS; HEART ARREST; HEART ELECTROPHYSIOLOGY; HOLTER MONITORING; HUMAN; MALE; RESUSCITATION; SCHOOL CHILD; SYMPTOM; SYNCOPE; TREADMILL EXERCISE;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; CHILD; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HUMANS; MALE; SEIZURES; SYNCOPE; TACHYCARDIA, VENTRICULAR;

EID: 65749102470     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951108003338     Document Type: Article

References (11)

1. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc D, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. Circulation 1995; 91: 1512-1519.
2. Sumitomo N, Harada K, Nagashima M, et al. Catecholaminergic polymorphic ventricular tachycardia: Electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 2003; 89: 66-70.
3. Celiker A. Polymorhic ventricular tachycardia. Türk Aritmi Pacemaker Elektrofizyoloji Dergisi 2005; 3: 107-110 (We can enable this report to readers who want to obtain a copy of the material).
4. Leite LR, Ponzi Pereira KR, Alessi SR, de Paola AA. Catecholaminergic polymorphic ventricular tachycardia. An important diagnosis in children with syncope and normal heart. Arq Bras Cardiol 2001; 76: 63-74.
5. Francis J, Sankar V, Nair VK, Priori SG. Catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2005; 2: 550-554.
6. Lahat H, Eldar M, Levy-Nissenbaum E, et al. Autosomal recessive catecholamine-or exercise-induced polymorphic ventricular tachycardia. Circulation 2001; 103: 2822-2827.
7. Massin M, Leroy P, Mission, Lepage P. Catecholaminergic polymorphic ventricular tachycardia in a child: An often unrecognized diagnosis. Archives de Pediatrie 2003; 10: 524-552.
8. Fischer J, Krikler D, Haalidie-Smith K. Familial polymorphic ventricular arrhythmias. J Am Coll Cardiol 1999; 34: 2015-2022.
9. Rosso R, Kalman JM, Rogowski O, et al. Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2007; 4: 1149-1154.
10. Priori S, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002; 106: 69-74.
11. Sumitomo N, Sakurada H, Taniguchi K, et al. Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia. Circ J 2007; 71: 1606-1609.